Smith & Nephew PLC | SN/

Smith & Nephew PLC traded at 1,133.00 this Tuesday March 28th, decreasing 7.00 or 0.61 percent since the previous trading session. Looking back, over the last four weeks, Smith & Nephew PLC lost 5.39 percent. Over the last 12 months, its price fell by 9.86 percent. Looking ahead, we forecast Smith & Nephew PLC to be priced at 1,102.14 by the end of this quarter and at 1,023.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
1,133.00
Daily Change
-0.61%
Yearly
-9.86%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Alcon AG 62.70 0.30 0.48% -16.76%
Essilor 158.60 -4.00 -2.46% -7.63%
Fresenius Medical Care 38.28 -0.21 -0.55% -36.18%
Fresenius 23.94 -0.08 -0.33% -27.75%
Getinge 239.70 -3.70 -1.52% -37.35%
GN Store Nord 140.70 -2.70 -1.88% -58.14%
GRIFOLS 8.93 -0.11 -1.19% -42.82%
Lonza Group 533.60 -4.40 -0.82% -20.62%
Philips 15.04 -0.18 -1.17% -46.93%
Reckitt Benckiser Group PLC 6,134.00 -2.00 -0.03% 6.60%
William Demant Holding 233.00 6.60 2.92% -23.61%

Indexes Price Day Year
GB100 7484 12.48 0.17% -0.70%

Smith & Nephew PLC
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.